Senegal vs Tajikistan: Estimated antiretroviral therapy coverage among people living with HIV
Senegal
77.0%
in 2025
Tajikistan
76.0%
in 2025
Senegal rank
64th
Tajikistan rank
66th
Estimated antiretroviral therapy coverage among people living with HIV over time
- Senegal
- Tajikistan
How they compare
Senegal currently reports 77.0% against 76.0% in Tajikistan, a difference of 1.0%.
The two have swapped places 1 time across 26 shared years of data; in 2000 it was Tajikistan ahead.
Senegal ranks 64th and Tajikistan ranks 66th of 143 countries.
Senegal has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Senegal | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.8% | 0.5% | 5.3% | Senegal |
| 2010s | 43.9% | 23.2% | 20.7% | Senegal |
| 2020s | 74.7% | 65.5% | 9.2% | Senegal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Senegal or Tajikistan?
- Senegal, at 77.0% against 76.0% in Tajikistan as of 2025.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Senegal and Tajikistan?
- 1.0%, with Senegal ahead.
- How many years of comparable data are there for Senegal and Tajikistan?
- 26 years are reported by both, from 2000 to 2025.
- How do Senegal and Tajikistan rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Senegal ranks 64th and Tajikistan ranks 66th of 143 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.